Key result
Radionuclide venography identified abnormal subclavian venous flow in 32.7% of asymptomatic patients with permanent pacemakers, which was more common in patients with larger leads.
Why the study?
Can radionuclide venography effectively diagnose abnormal subclavian venous flow due to leads in patients with permanent pacemakers?
Cross-Sectional (n=52)
Can radionuclide venography effectively diagnose abnormal subclavian venous flow due to leads in patients with permanent pacemakers?
Radionuclide venography is a safe, noninvasive method for detecting subclavian venous flow abnormalities, which are more common in patients with larger pacemaker leads.
May identify subclinical venous abnormalities in asymptomatic pacemaker patients; hypothesis-generating for larger lead effects, warranting prospective evaluation.
In this study, we investigated the role of radionuclide venography in the diagnosis of abnormal subclavian venous flow due to the lead in patients (pts) with permanent pacemakers. The study was conducted with 53 frames in 52 asymptomatic pts (26 females, mean age 64.5 +/- 15; range 25-89 years). The mean time after implant was 67.6 +/- 47.5 months. Technetium 99m pertecnetate (250 MBq) was given to both antecubital veins simultaneously. The images were acquired in 0.25-second frames for 20 seconds. The pts were evaluated visually in terms of the activity flow through the subclavian veins bilaterally. The retrograde flow in the jugular vein, decrease in flow rate, and subtotal and total obstruction of the subclavian veins were accepted as abnormal venous flow patterns. In 17 pts with abnormal findings, 10 (58.8%) had retrograde flow in the jugular vein, 4 had (23.5%) decreased flow rate, 1 (5.8%) had subtotal and 2 (11.7%) total obstruction in the subclavian vein. The mean of the body diameter of the leads was significantly greater and the percentage of the silicone-insulated leads was higher (76% vs 52%) in the group with abnormal flow. No complication due to the procedure was seen. In conclusion, radionuclide venography, a noninvasive method, may be used easily and safely to show the venous flow abnormalities due to the lead in pts with permanent pacemakers. The abnormal subclavian venous flow was especially seen in pts who had larger leads.
No takes yet. Share an insight, caveat, or question.
Çeliker et al. (1998) conducted a cross-sectional in Asymptomatic patients with permanent pacemakers (n=52). Radionuclide venography was evaluated on Abnormal subclavian venous flow. Radionuclide venography identified abnormal subclavian venous flow in 32.7% of asymptomatic patients with permanent pacemakers, which was more common in patients with larger leads.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: